Amiloride: Clinical Trials

14 trials of Amiloride, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 3 unknown, 1 active not recruiting. 14 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 414Completed 10, Unknown 3, Active not recruiting 1

Follow Amiloride: new trials by email Literature Review of Amiloride trials Research Report on Amiloride

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
AMIloride for the Treatment of Nephrogenic Diabetes Insipidus for Patients With Bipolar Disorder Treated With Lithium
Anhydrous Amiloride Hydrochloride, Placebo - Bipolar Disorder
Phase 4Active not recruitingAssistance Publique - Hôpitaux de Paris1482023-01-112025-05-09
Treatment of Vascular Stiffness in ADPKD
Sodium chloride (NaCl), Placebo, Amiloride Hcl 5mg Tab - Autosomal Dominant Polycystic Kidney
Phase 4CompletedErasmus Medical Center462022-03-112025-08-17
Comparison of Spironolactone and Amiloride on Home Blood Pressure in Resistant Hypertension
Spironolactone, Amiloride - Resistant Hypertension
Phase 4CompletedYonsei University1182020-11-162024-09-24
A New Application of Amiloride in the Treatment of Patient With Chronic Kidney Disease In Reducing Urinary PROtein
Amiloride, Hydrochlorothiazide - Chronic Kidney Diseases
Phase 4CompletedGuangdong Provincial People's Hospital402018-03-012020-09-18
Comparison of Optimal Hypertension Regimens
Amlodipine, Lisinopril, Amiloride - Hypertension
Phase 4CompletedCambridge University Hospitals NHS Foundation Trust9402016-11-012025-09-05
DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease
Amiloride, Hydrochlorothiazide, Low-sodium diet - Chronic Kidney Disease
Phase 4CompletedErasmus Medical Center282016-09-012018-04-20
Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial Hypertension
Spironolactone, Furosemide,, Amiloride - Hypertension Resistant to Conventional Therapy
Phase 4CompletedSao Jose do Rio Preto Medical School722015-09-012019-04-05
A Crossover Pilot Study of the Effect of Amiloride on Proteinuria
Amiloride, Triamterene - Proteinuria
Phase 4UnknownGeorgetown University302013-07-012020-02-07
Amiloride for Resistant Hypertension
Amiloride - Hypertension, Type 2 Diabetes Mellitus
Phase 4CompletedIb Abildgaard Jacobsen802010-11-012014-04-24
The Effect of Amiloride and Spironolactone in Patients With Hypertension
Spironolactone, Amiloride, Placebo - Hypertension
Phase 4CompletedErling Bjerregaard Pedersen232010-09-012012-03-28
Study of Amiloride on Vascular Phenotypes in Young Adults With Prehypertension
Amiloride - Prehypertension
Phase 4UnknownAugusta University322010-09-012012-10-23
Comparison of Single and Combination Diuretics in Low-Renin Hypertension
Hydrochlorthiazide, Amiloride, Hydrochlorthiazide and Amiloride - Hypertension
Phase 4UnknownUniversity of Cambridge4232009-11-012015-07-03
Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI
Guaifenesin, Placebo - Acute Upper Respiratory Track Infection
Phase 4CompletedReckitt Benckiser Inc.11792009-10-012020-12-30
Phase 4 Study - Mucinex D as Adjunct Therapy
Mucinex D (600 mg guaifenesin and 60 mg pseudoephedrine HCl extended-release bi-layer tablets) - Acute Respiratory Infection, Bronchitis
Phase 4CompletedAdams Respiratory Therapeutics6002007-02-012008-02-06

Conditions studied

Hypertension (5)  ·  Renal Insufficiency, Chronic (2)  ·  Bipolar Disorder (1)  ·  Bronchitis (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Hypertension Resistant to Conventional Therapy (1)  ·  Polycystic Kidney Diseases (1)  ·  Polycystic Kidney, Autosomal Dominant (1)  ·  Prehypertension (1)  ·  Proteinuria (1)  ·  Rhinosinusitis (1)

Sponsors

Erasmus Medical Center (2)  ·  Adams Respiratory Therapeutics (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Augusta University (1)  ·  Cambridge University Hospitals NHS Foundation Trust (1)  ·  Erling Bjerregaard Pedersen (1)  ·  Georgetown University (1)  ·  Guangdong Provincial People's Hospital (1)  ·  Ib Abildgaard Jacobsen (1)  ·  Reckitt Benckiser Inc. (1)  ·  Sao Jose do Rio Preto Medical School (1)  ·  University of Cambridge (1)  ·  Yonsei University (1)

Countries

United States (4)  ·  Denmark (2)  ·  Netherlands (2)  ·  United Kingdom (2)  ·  Brazil (1)  ·  China (1)  ·  France (1)  ·  South Korea (1)

Top investigators

Ewout J Hoorn, MD, PhD (1)  ·  Helmut Albrecht, M.D. (1)  ·  Ian Wilkinson (1)  ·  Ib A Jacobsen, DMSc (1)  ·  Juan C Yugar-Toledo, MD, PhD (1)  ·  M. Salih, MD, PhD (1)  ·  Professor MJ Brown (1)  ·  Solveig K Matthesen, Cand.Med (1)  ·  Sungha Park (1)  ·  Wen Shen, MD, PhD (1)

Results publications

PMID 12479763, PMID 15106785, PMID 18391085, PMID 20651602, PMID 21423678, PMID 21444835, PMID 21502568, PMID 22948302, PMID 24410943, PMID 26253567, PMID 28761581, PMID 29433578, PMID 30092411, PMID 31791376, PMID 31996411, PMID 33957621, PMID 34164803, PMID 39356039, PMID 40366680, PMID 40859651, PMID 42247265

NIH funding

2009 (1)